These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1832137)

  • 1. Immunohistochemical staining for ferritin in neuroblastomas.
    Carter RL; Hall JM; Corbett RP
    Histopathology; 1991 May; 18(5):465-8. PubMed ID: 1832137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastomas contain iron-rich ferritin.
    Iancu TC; Shiloh H; Kedar A
    Cancer; 1988 Jun; 61(12):2497-502. PubMed ID: 3365671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and immunohistochemical investigation of neuroblastomas and correlation with prognosis.
    Brook FB; Raafat F; Eldeeb BB; Mann JR
    Hum Pathol; 1988 Aug; 19(8):879-88. PubMed ID: 2969864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children.
    Carter RL; al-Sams SZ; Corbett RP; Clinton S
    Histopathology; 1990 May; 16(5):461-7. PubMed ID: 2163356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron and neoplasia: ferritin and hemosiderin in tumor cells.
    Iancu TC
    Ultrastruct Pathol; 1989; 13(5-6):573-84. PubMed ID: 2799988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin in stage IV neuroblastoma.
    Imashuku S; Yamanaka H; Morioka Y; Todo S
    Am J Pediatr Hematol Oncol; 1988; 10(1):39-41. PubMed ID: 3189716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical assessment of ferritin in bone marrow trephine biopsies: correlation with marrow hemosiderin.
    Navone R; Azzoni L; Valente G
    Acta Haematol; 1988; 80(4):194-8. PubMed ID: 2464264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First experience with prognostic factors in unselected neuroblastoma patients. The Austrian Neuroblastoma 87 Study.
    Ladenstein R; Urban C; Gadner H; Fink FM; Zoubek A; Emminger W; Grienberger H; Schmitt K; Ambros PF; Ambros IM
    Eur J Cancer; 1995; 31A(4):637-41. PubMed ID: 7576985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma of parotid gland: report of a case and immunohistochemical characteristics.
    Shrestha P; Yang L; Liu B; Namba M; Takagi H; Hosaka M; Mori M
    Eur J Cancer B Oral Oncol; 1994 Sep; 30B(5):356-61. PubMed ID: 7703807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic and immunohistochemical features of neuroblastoma: a tool for evaluating prognosis.
    Bigotti G; Coli A
    Tumori; 1990 Aug; 76(4):374-8. PubMed ID: 2399568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic immunohistochemistry of neuroblastic tumors.
    Wirnsberger GH; Becker H; Ziervogel K; Höfler H
    Am J Surg Pathol; 1992 Jan; 16(1):49-57. PubMed ID: 1530805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological indicators with a prognostic significance in neuroblastoma in children].
    Pein F; Hartmann O
    Bull Cancer; 1988; 75(1):83-6. PubMed ID: 3359058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience.
    Hann HW; Evans AE; Siegel SE; Wong KY; Sather H; Dalton A; Hammond D; Seeger RC
    Cancer Res; 1985 Jun; 45(6):2843-8. PubMed ID: 3986811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload.
    Miyazaki E; Kato J; Kobune M; Okumura K; Sasaki K; Shintani N; Arosio P; Niitsu Y
    Gut; 2002 Mar; 50(3):413-9. PubMed ID: 11839724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferritin in neuroblastoma. Impact of tumor load and blood transfusions.
    Potaznik D; de Sousa M; Helson L; Bagin R; Groshen S; Bhalla RB
    Cancer Invest; 1985; 3(4):327-38. PubMed ID: 4027755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical studies on the innervation of human transplanted liver.
    Dhillon AP; Sankey EA; Wang JH; Wightman AK; Mathur S; Burroughs AK; Scheuer PJ
    J Pathol; 1992 Jun; 167(2):211-6. PubMed ID: 1386106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Neuroendocrine' differentiation in primary neoplasms of the liver.
    Wang JH; Dhillon AP; Sankey EA; Wightman AK; Lewin JF; Scheuer PJ
    J Pathol; 1991 Jan; 163(1):61-7. PubMed ID: 1848288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children.
    Hann HW; Evans AE; Cohen IJ; Leitmeyer JE
    N Engl J Med; 1981 Aug; 305(8):425-9. PubMed ID: 7254280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factor in neuroblastoma.
    Evans AE; D'Angio GJ; Propert K; Anderson J; Hann HW
    Cancer; 1987 Jun; 59(11):1853-9. PubMed ID: 3567848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.